H37Ra suspended in 1.25% mineral oil emulsion cured established tumors in the skin and metastases in draining lymph nodes of guinea pigs (strain 2) after intratumoral administration in 33% of the cases examined. This was increased to 83% when a mixture of cord factor and the delipidated cell walls was used. A similarly high percentage of cures was obtained after administration of lyophilized, killed BCG alone or with addition of cord factor in 1% mineral oil emulsion. Lyophilized, killed BCG dispersed in a solution of tocopherol acetate in peanut oil or in peanut oil alone showed a limited tumor-regressive activity (36%). However, a mixture of BCG and cord factor suspended in the above media cured 80 and 69% of the treated animals, respectively.
Guinea pigs with a transplanted hepatocellular carcinoma (Line 10) in their skin and metastases in their regional lymph nodes can be cured by the intralesional injection of living BCG (36) . Killed BCG or BCG cell walls suspended in saline are not therapeutic in this system. Cures comparable to those produced by living BCG, however, have been produced by the intralesional injection of BCG cell wall fragments attached to mineral oil which was emulsified in an aqueous solution of saline containing Tween 80 (35) . One of the components of the mycobacterial cell wall is cord factor (CF; trehalose-6,6'-dimycolate; [17, 24] ), a compound which possesses some of the biological properties of living BCG. Both agents produce granulomas in lungs of mice after an intravenous injection (4) . After administration into footpads of mice, both agents induce in the draining lymph nodes granuloma formation, hyperplasia in the paracortical region, and accumulation of. macrophages, changes which are apparently responsible for increased antibody formation to an unrelated antigen, which is subsequently injected into the same site (5, 8) . CF suppresses the development of urethaneinduced tumors in the lungs of mice to an extent similar to that produced by living BCG. This suppression was attributed to the granulomatous reaction induced in the lungs of mice by both agents (6) . It has also been reported that CF prevents the growth of Ehrlich ascites cells in the peritoneal cavities of mice as do living or dead BCG cells (33) .
It was conceivable that CF (which simulates some of the biological activities of living BCG) plays a role in regression of tumors after intralesional injections of living BCG or mycobacterial cell walls. The purpose of this work was to test this assumption and to attempt to cure established tumors with nonliving BCG.
MATERIALS AND METHODS Animals. Male guinea pigs of the Sewall-Wright inbred strain 2 weighing 400 to 500 g were supplied by the Animal Production Section, National Institutes of Health and Frederick Cancer Research Center and Animal Farm (Fort Detrick, Frederick, Md.). They were fed Wayne guinea pig chow ad libitum and were given kale twice weekly. In skin tests with the preparation of mycobacterial fractions, guinea pigs of a local strain were used.
Preparation of mycobacterial fractions. CF was prepared as described previously (4) and purified by thin-layer chromatography; its identity was checked by optical rotation, infrared and mass spectra, and the analysis of its components: mycolic acids and trehalose (R. Tubiana and E. Lederer, in preparation). The cell walls of Mycobacterium tuberculosis strain H37Ra were prepared and freed of extraneous, noncovalently linked lipid, protein, and glycolipid by exhaustive extractions with organic solvents, as well as by enzymatic digestion (2, 25 [27] ). An hepatocarcinoma designated Line 10 was induced with diethylnitrosamine in strain 2 guinea pigs and was subsequently adapted to the ascites form (27) . Methods of tumor passage and inoculation have been described by Zbar et al. (37) . After VOL. 10, 1974 tween these groups and the control emulsion groups was significant (P <0.05). It is noteworthy that the lymph nodes in these guinea pigs enlarged soon after injection of the cell wall fraction, and, at the time when the tumor was already locally healed, the enlarged nodes decreased in size and slowly became unpalpable. A clear-cut increase of complete cures was attained when CF was added to the delipidated and deproteinized cell walls. In three experiments, the healing of the tumors was already evident at the end of the first week, after administration of the mixture. Also in these cases, the draining nodes were enlarged even after the tumors were locally healed, but they slowly decreased to normal size. The results of the three experiments are statistically significant compared with groups treated with delipidated and deproteinized cell walls only (P <0.01).
The lysozyme cell wall digest, a product derived from the delipidated and deproteinized cell walls of H37Ra, was also able to cure the tumors to a degree similar to the delipidated and deproteinized cell walls. However, mixtures of the lysozyme cell wall fraction and CF, injected into the tumor, gave the following conflicting results.
Guinea pigs in which there was complete regression of the tumors locally and in the lymph nodes were rechallenged with 106 tumor cells on the flank opposite the original tumor site. Out of 18 guinea pigs 17 rejected the challenge, indicating that the cured guinea pigs acquired immunity to Line 10 tumor cells.
Tumor-regressive ability of nonliving BCG. Heat-killed BCG cells (106 to 107) were unable to cause a cellular response in the lungs of mice after an intravenous injection or any significant change in the draining lymph nodes after administration into their footpads, unless the bacilli were attached to oil and emulsified in an aqueous solution of saline to which Tween 80 was added as an emulsifier. Similarly, a saline suspension of dead bacilli introduced into the skin of guinea pigs caused a slight and transient reaction (unpublished data; 7). It was assumed that BCG cells attached to oil should be able to cause regression of established tumors at least to the same degree as living BCG. It was also assumed that, since the tumor-regressive ability depends on the inflammatory cellular reaction of the host, the stronger this reaction the better the therapy result will be. Addition of CF to BCG cells would intensify this reaction and increase the effectiveness of the BCG cells. Before testing these assumptions, skin reactions in guinea pigs were observed after intradermal administrations of emulsion, CF alone, BCG cells plus cord factor, and BCG cells alone. All preparations induced an inflammatory reaction in the form of nodules with an erythema and induration. However, there were marked differences in their intensity. The weakest reaction was induced by emulsion and the strongest was induced by the mixtures of CF and BCG cells. In the latter case, necrosis was always evident in the center of the nodule. A slight necrotic center was also present at the site of injection of CF; after 10 days, no signs of reaction were present at the site of administration of emulsion. The reactions were observed for 20 days; at that time, induration at the site of injection of BCG and BCG plus CF was still evident. this question definitely. However, there was a difference between the local inflammatory reactions after administration of BCG cells and the mixture of BCG plus CF. In the latter case, the reaction was much stronger. As soon as 4 days after injection of the mixture, the area of the tumor and beyond was covered with an almost black crust of necrotic tissue; the large nodule which appeared at the site of the tumor after administration of the mixture shrank very rapidly; the crust of necrotic tissue was rejected and usually local cures are evident at the end of the second week after injection. At that time the regional node was enlarged, but then it decreased in size and slowly became impalpable. The process of tumor rejection in the BCG group was slower.
Therapy of tumors with BCG cells suspended in solutions of tocopherol in peanut oil. In the years that followed the introduction of complete Freund adjuvant, attempts were made to develop an adjuvant from vegetable oils (7, (11) (12) (13) 32 were present, especially at the sites of administration of CF and BCG plus CF. Signs of inflammation at the site of injection of vitamin E disappeared after 2 weeks. At the sites of administration of BCG plus CF and BCG alone, induration was still present after 3 weeks. At that time, only slight erythema at the site of CF injection was evident.
The results of the immunotherapy experiment are presented in Table 3 . It was surprising that BCG cells did not show any tumor regressive activity in the first experiment. There were local healings, but metastases in the nodes appeared, grew, and killed the animals. However, in a second experiment, four out of six animals were cured. CF in one experiment cured two out of four animals but in another none out of five were cured. The mixtures of CF plus BCG were very effective; 80% of the animals were cured.
After establishing that administrations into the skin of guinea pigs of CF, BCG plus CF, and BCG alone in peanut oil caused a similar inflammatory reaction to the one caused by the medium of the oil with addition of tocopherol, therapy experiments were carried out using the aThe fractions were suspended in 5% of D,L-a-tOcopherolacetate in peanut oil. oil alone as the medium (Table 4) . The results were similar to those presented in Table 3 .
Effect of the cellular (inflammatory) reaction induced by living BCG on tumor development. It has been assumed that stimulation of the immune response by mycobacterial adjuvants (and among them, by living BCG) to unrelated antigens was due to the cellular inflammatory reaction of the host at the sites of the lodgment of the adjuvants and multiplication (in the case of living BCG). This may take place in the skin, lymph nodes, reticuloendothelial system, lungs, and peritoneal cavity (4-6, 8, 33) . To test this assumption, 1 .45 x 106 living BCG cells were injected intradermally into four guinea pigs. The pathological change at the injection site began as usual with a very mild reaction which developed progressively into a granulomatotus nodular lesion. Seven days after administration of BCG, 106 Line 10 tumor cells were injected into the indurated tissue at the site of injection and on the opposite site into normal skin. It soon became clear that the growth of the tumor in the granulomatous lesion was strongly inhibited, whereas on the opposite site it developed quite normally (Fig. 2) . In two out of the four, the tumors regressed locally at the sites of the nodules. Similar results were obtained after treating the nodules with nonliving BCG alone or BCG plus CF in 1% mineral oil emulsions. DISCUSSION It is clear from the present study that trehalose-6,6'-dimycolate (CF), a component of the mycobacterial cell wall, takes part in the tumorregressive activity of living BCG or of cell walls. had to be added to the delipidated cell wall to increase the tumor-regressive ability of the latter. An enhancement of antitumor activity of delipidated BCG cell walls by addition of mycobacterial lipid designated P3 has recently been reported (21) . It has been observed during this study that the lipid-and protein-free cell wall of H37Ra and its lysozymal digest (injected intradermally into guinea pigs in amounts of 100 Mg) caused delayed hypersensitivity to 2 ,ug of purified protein derivative (Connaught Medical Research Laboratories, Toronto, Ontario). CF had no such effect, and it seemed that to cause tumor regression, cellular components of a hypersensitivity reaction had to be present at the site of tumor. However, since CF alone in the peanut oil solution of tocopherol acetate (or in peanut oil alone) showed tumor-regressive activity in some cases, it may be that effector cells appear in every chronic inflammatory reaction, but the outcome of antitumor activity may depend on their quantity and predominance of certain cells (probably lymphocytes T and B types or a third type, besides macrophages). This problem is under investigation.
The lysozymal cell wall digest of H37Ra cell walls showed tumor-regressive activity similar to that of the delipidated and deproteinized cell walls. However, mixtures with CF injected into tumors gave conflicting results. In one experiment, a high percentage of cures was achieved; in two others, no cures were achieved at all. In the latter case, the impression was left that there was an enhancement of the tumor growth. The (30) . It has also proved effective in lengthening remissions in acute leukemia (20) . However, living BCG can cause disseminated disease in an immunosuppressed host (10, 14, 18, 19, 29) . Although local reactions at the site of injections may be severe, they generally disappear (16, 31) . Seventeen deaths from generalized infection with BCG have been reported also during large scale vaccination (10, 18, 29) .
It seems that these adverse effects of using living BCG can be avoided by using lyophilized, killed BCG alone, with CF in 1% emulsions of mineral oil or with BCG and CF in peanut oil as used in this work. The high percentage of cures and the reproducibility of the results obtained in the present work justifies the assumption that the above preparations could also be more effective than living BCG in immunotherapy of cancer in humans. There are different living strains of BCG in use for vaccination; all of them are probably effective in vaccinating against tuberculosis, but not all of them are effective in immunotherapy of experimental cancer (Zbar, personal communication) . The same situation exists in therapy (with living BCG) of cancer in man.
It is noteworthy that the content of CF may be different in different strains of BCG (3). This may explain the different efficacy of the strains in immunotherapy experiments. This effectiveness is apparently dependent on the cellular reaction induced in the host at the site of lodgment of the bacteria as has been shown in this work. The therapy results received in this work, and the evidence that a suitable inflammatory cellular reaction of the host is necessary for tumor destruction, call not only for application in humans, but also for further investigations, such as the mechanism and nature of tumor regression and the very important practical question of controlling tumors in sites other than the skin.
